The present study examined the prevalence and correlates of insomnia and fatigue in patients with type-2 diabetes in Jordan.
Methods
This was a cross-sectional online study involving a convenience sample of 390 patients with type-2 diabetes. Insomnia was assessed by the Insomnia-Severity Index (ISI-A) and fatigue by the Brief Fatigue Inventory (BFI-A).
Results
Severe insomnia was present in 132 patients (33.8%), and was correlated with length of diabetes (diagnosis >5 years) (OR = 2.13, 95% CI = 1.19-3.81, P = 0.01), presence of uncontrolled diabetes (OR = 1.97, 95% CI = 1.45-2.69, P < 0.001), taking gabapentin (OR = 2.07, 95% CI = 1.07-4.01, P = 0.003), and age (<40 years) (OR = 0.30, 95% CI = 0.13-0.69, P = 0.005). Significant fatigue was also prevalent and correlated with gender (female) (B = 9.25, t = 4.48, P < 0.001), age (<40 years) (B = 7.56, t = 2.56, P = 0.01), a diagnosis of hypertension (B = 4.74, t = 2.03, P = 0.04), uncontrolled diabetes (B = 7.21, t = 4.82, P < 0.001), and taking a sulfonylurea (B = 8.03, t = 3.37, P < 0.001), carbamazepine (B = 10.93, t = 2.65, P = 0.008), or gabapentin (B = 12.60, t = 3.83, P < 0.001).
Conclusion
Given the high prevalence of insomnia and fatigue in this population, increased attention by primary healthcare providers to these symptoms in diabetic patients is warranted, particularly in developing countries such as Jordan.
OlokobaABObateruOAOlokobaLB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27(4):269-273.
2.
AjlouniKBatiehaAJaddouH, et al.Time trends in diabetes mellitus in Jordan between 1994 and 2017. Diabet Med. 2019;36(9):1176-1182.
3.
AwadSFHuangfuPDarghamSR, et al.Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050. Sci Rep. 2020;10(1):21001.
4.
BudhirajaRRothTHudgelDWBudhirajaPDrakeCL. Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep. 2011;34(7):859-867.
5.
Salem GammohOAlqudahAQnaisEAlotaibiBS. Factors associated with insomnia and fatigue symptoms during the outbreak of Oct. 7th war on Gaza: a study from Jordan. Prev Med Rep. 2024;41:102685.
6.
WalshJKCoulouvratCHajakG, et al.Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep. 2011;34(8):997-1011.
7.
NasirNFMDramanNZulkifliMMMuhamadRDramanS. Sleep quality among patients with type 2 diabetes: a cross-sectional study in the East Coast region of Peninsular Malaysia. Int J Environ Res Publ Health. 2022;19(9):5211.
8.
PlantingaLRaoMNSchillingerD. Prevalence of self-reported sleep problems among people with diabetes in the United States, 2005-2008. Prev Chronic Dis. 2012;9:E76.
9.
AlamerWMQutubRMAlsaloumiEANattoNKAlshehriRMKhafagyA. Prevalence of sleep disorders among patients with type 2 diabetes mellitus in Makkah City: a cross-sectional study. Cureus. 2022;14(12):e33088.
10.
DarrajAMahfouzMSAlsabaaniASaniMAlameerA. Assessment of sleep quality and its predictors among patients with diabetes in Jazan, Saudi Arabia. Diabetes Metab Syndr Obes. 2018;11:523-531.
11.
NarisawaHKomadaYMiwaT, et al.Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes. Neuropsychiatric Dis Treat. 2017;13:1873-1880.
12.
JemereTMossieABerhanuHYeshawY. Poor sleep quality and its predictors among type 2 diabetes mellitus patients attending Jimma University Medical Center, Jimma, Ethiopia. BMC Res Notes. 2019;12:488.
13.
HafnerMRomanelliRJYerushalmiETroxelWM. The Societal and Economic Burden of Insomnia in Adults; 2023: 1-99.
14.
DaleyMMorinCMLeBlancMGrégoireJ-PSavardJ. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep. 2009;32(1):55-64.
15.
WickwireEMShayaFTScharfSM. Health economics of insomnia treatments: the return on investment for a good night’s sleep. Sleep Med Rev. 2016;30:72-82.
16.
KyleSDMorganKEspieCA. Insomnia and health-related quality of life. Sleep Med Rev. 2010;14(1):69-82.
17.
IshakWWBagotKThomasS, et al.Quality of life in patients suffering from insomnia. Innov Clin Neurosci. 2012;9(10):13-26.
18.
AaronsonLSTeelCSCassmeyerV, et al.Defining and measuring fatigue. Image - J Nurs Scholarsh. 1999;31(1):45-50.
19.
FritschiCQuinnL. Fatigue in patients with diabetes: a review. J Psychosom Res. 2010;69(1):33-41.
20.
RomadlonDSHasanFWiratamaBSChiuH-Y. Prevalence and risk factors of fatigue in type 1 and type 2 diabetes: a systematic review and meta-analysis. J Nurs Scholarsh. 2022;54(5):546-553.
21.
SeoY-MHahmJ-RHahmJRKimTKChoiWH. Factors affecting fatigue in patients with type II diabetes mellitus in Korea. Asian Nurs Res. 2015;9(1):60-64.
22.
KuoH-JHuangY-CGarciaAA. An integrative review of fatigue in adults with type 2 diabetes mellitus: implications for self-management and quality of life. J Clin Nurs. 2022;31(11–12):1409-1427.
SuleimanKHYatesBC. Translating the insomnia severity index into Arabic. J Nurs Scholarsh. 2011;43(1):49-53.
25.
MendozaTRWangXSCleelandCS, et al.The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186-1196.
26.
SuleimanKAl KalaldehMAbuSharourL, et al.Validation study of the Arabic version of the Brief fatigue inventory (BFI-A). East Mediterr Health J. 2019;25(11):784-790.
27.
BhaskarSHemavathyDPrasadS. Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities. J Fam Med Prim Care. 2016;5(4):780-784.
28.
ChengM-YWangM-JChangM-YZhangR-XGuC-FZhaoY-H. Relationship between resilience and insomnia among the middle-aged and elderly: mediating role of maladaptive emotion regulation strategies. Psychol Health Med. 2020;25(10):1266-1277.
29.
GammohOBjørkM-HAl RobOAAlQudahARHaniABAl-SmadiA. The association between antihypertensive medications and mental health outcomes among Syrian war refugees with stress and hypertension. J Psychosom Res. 2023;168:111200.
30.
BarakatSAbujbaraMBanimustafaRBatiehaAAjlouniK. Sleep quality in patients with type 2 diabetes mellitus. J Clin Med Res. 2019;11(4):261-266.
31.
DingCZhangJLauESH, et al.Gender differences in the associations between insomnia and glycemic control in patients with type 2 diabetes: a cross-sectional study. Sleep. 2019;42(4):zsz014.
32.
IsmyJEmrilDRKhalilullahSAMaunyMP. Evaluation of gabapentin as a treatment of breakthrough cancer pain caused by metastatic prostate adenocarcinoma. J Pain Res. 2023;16:3319-3324.
33.
HongJSWAtkinsonLZAl-JuffaliN, et al.Gabapentin and Pregabalin in bipolar disorder, anxiety states, and insomnia: systematic review, meta-analysis, and rationale. Mol Psychiatr. 2022;27(3):1339-1349.
BackonjaM-M. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus 1. Epilepsia. 1999;40:s57-s59.
36.
FritschiCQuinnLHackerED, et al.Fatigue in women with type 2 diabetes. Diabetes Educat. 2012;38(5):662-672.
37.
KimHK. Fatigue and factors influencing fatigue in middle-aged adults by age groups. Korean J Women Heal Nurs. 2006;12(4):273-281.
38.
SinghRKludingPM. Fatigue and related factors in people with type 2 diabetes. Diabetes Educ. 2013;39(3):320-326.
39.
NaseriMWEsmatHABaheeMD. Prevalence of hypertension in Type-2 diabetes mellitus. Ann Med Surg. 2022;78:103758-103762.
40.
KimJHSeoMYHongSD, et al.The efficacy of preemptive analgesia with pregabalin in septoplasty. Clin Exp Otorhinolaryngol. 2014;7(2):102-105.
41.
RafiullahMSiddiquiK. Pharmacological treatment of diabetic peripheral neuropathy: an update. CNS Neurol Disord: Drug Targets. 2022;21(10):884-900.
42.
SiniscalchiAGallelliLRussoEDe SarroG. A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. Eur J Pharmacol. 2013;718(1–3):10-16.
